Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Hank Payments Achieves Record Growth in its Profitable Auto Channel (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Helius Medical Technologies Inc HSDT

Healthcare Medical Devices
Helius Medical Technologies, Inc. is a neurotech company in the medical device field. It is focused on neurologic deficits using orally applied technology platform that amplifies the brain’s ability to engage physiologic compensatory mechanisms enhancing the lives of people dealing with neurologic diseases. It develops, licenses, or acquires non-implantable technologies targeted at reducing symptoms of neurological disease or trauma. Its product Portable Neuromodulation Stimulator (PoNS) is a non-implantable medical device, inclusive of a controller and mouthpiece, which delivers mild electrical stimulation to the surface of the tongue to provide treatment of gait deficit and chronic balance deficit. PoNS Therapy is integral to the overall PoNS solution and is the physical therapy applied by patients during use of the PoNS neuromodulation stimulator. PoNS is used as an adjunct to a supervised therapeutic exercise program in patients 22 years of age and over by prescription only.


NDAQ:HSDT - Post by User

Helius Medical Technologies Inc
Bullboard Posts
User Avatar Image
(2)
•••
Comment by prokofievon Sep 07, 2018 5:54pm
193 Views
Post# 28582668

RE:RE:RE:Heuro - PoNs therapy branding in Canada

RE:RE:RE:Heuro - PoNs therapy branding in CanadaThis is the company behind Heuro.ca, based in Surrey, BC. 

https://healthtechconnex.com/services/

The Heuro.ca website states "the use of non-invasive, innovative medical devices", implying more than the PoNS. I would make a ton of sense to combine it with their NeuroCatch Platform (NeuroCatch) which measures & assesses brain health (auditory processing, basic attention and cognitive processing). 

Most importantly, these clinics (two of the 7 TBI trial sites - they have seen patient's lives improving first hand) are moving forward and spending money before the FDA approval. Speaks volumes...  

Prokofiev


PMoney79 wrote: The two canadian sites appear to be the clinics that participated in the TBI trial. During yesterdays presentation the CEO planned on having 5 CEPs up and running by the end of 2018. 

We will be seeing revenue in the Q4 2018 earning release in 2018.

The CEO also stated that the FDA takes 90-150 days.   150 days is Feb. 1st. so it will be an interesting 6 months.


Bullboard Posts
Dealroom for high-potential pre-IPO opportunities